Novo Nordisk (Germany) Price on March 3, 2024
NOVA Stock | EUR 103.50 1.50 1.43% |
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Novo Nordisk stands at 103.50, as last reported on the 12th of December 2024, with the highest price reaching 106.50 and the lowest price hitting 103.50 during the day. Novo Nordisk AS has Sharpe Ratio of -0.15, which conveys that the firm had a -0.15% return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Risk Adjusted Performance of (0.06), mean deviation of 1.35, and Standard Deviation of 1.78 to check out the risk estimate we provide.
Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Novo |
Sharpe Ratio = -0.1519
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NOVA |
Estimated Market Risk
1.72 actual daily | 15 85% of assets are more volatile |
Expected Return
-0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.
Novo Nordisk Valuation on March 3, 2024
It is possible to determine the worth of Novo Nordisk on a given historical date. On March 3, 2024 Novo was worth 108.19 at the beginning of the trading date compared to the closed value of 113.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novo Nordisk stock. Still, in general, we apply an absolute valuation method to find Novo Nordisk's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novo Nordisk where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novo Nordisk's related companies.
Open | High | Low | Close | Volume | |
110.66 | 111.16 | 109.18 | 109.18 | 1,365 | |
03/01/2024 | 108.19 | 113.63 | 108.19 | 113.13 | 357.00 |
112.64 | 117.09 | 112.64 | 116.59 | 3,836 |
Backtest Novo Nordisk | | | Novo Nordisk History | | | Novo Nordisk Valuation | Previous | Next |
Novo Nordisk Trading Date Momentum on March 3, 2024
On March 04 2024 Novo Nordisk AS was traded for 116.59 at the closing time. The maximum traded price for the trading interval was 117.09 and the lowest daily price was 112.64 . The daily volume was recorded at 3.8 K. The volume of trading on 4th of March 2024 played a part in the next trading day price rise. The trading delta at closing time to the next closing price was 3.06% . The trading delta at closing time to the closing price today is 7.87% . |
Novo Nordisk AS Fundamentals Correlations and Trends
By evaluating Novo Nordisk's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novo Nordisk's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novo Nordisk Stock history
Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Novo Nordisk AS, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. NOVO NORDISK is traded on Frankfurt Stock Exchange in Germany.
Novo Nordisk Stock Technical Analysis
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novo Nordisk Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Novo Nordisk AS cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novo Nordisk December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk stock market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns
Novo Nordisk Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.20) | |||
Total Risk Alpha | (0.46) | |||
Treynor Ratio | (1.10) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |